Lixte Biotech Hlds (LIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,010 | -3,586 | -5,087 | -6,313 | -6,728 |
| Accounts payable and accrued liabilities | 381 | -74 | -74 | 2 | 36 |
| Other Working Capital | 413 | 3 | -48 | 155 | -13 |
| Other Operating Activity | 2,145 | 492 | 916 | 1,544 | 2,563 |
| Operating Cash Flow | $-3,071 | $-3,165 | $-4,293 | $-4,612 | $-4,143 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | -440 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -2,637 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -2,733 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-3,173 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,311 | N/A | 3,143 | 5,141 | 3,908 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -11 |
| Financing Cash Flow | $10,311 | $N/A | $3,143 | $5,141 | $3,897 |
| Beginning Cash Position | 1,039 | 4,204 | 5,353 | 4,824 | 5,069 |
| End Cash Position | 5,107 | 1,039 | 4,204 | 5,353 | 4,824 |
| Net Cash Flow | $4,068 | $-3,165 | $-1,150 | $530 | $-246 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,071 | -3,165 | -4,293 | -4,612 | -4,143 |
| Free Cash Flow | -3,071 | -3,165 | -4,293 | -4,612 | -4,143 |